Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2022 Dec 7;270(3):1654–1661. doi: 10.1007/s00415-022-11499-9

Profile of precipitating factors and its implication in 160 Indian patients with Moyamoya angiopathy

Shambaditya Das 1, Biman Kanti Ray 1, Alak Pandit 1, Ritwik Ghosh 2, Rolf Diehl 3, Souvik Dubey 1, Markus Kraemer 3,4,
PMCID: PMC9734856  PMID: 36477636

Abstract

Introduction

Moyamoya angiopathy (MMA) has been known to manifest with myriad of neurological manifestations, often in association with various precipitating factors. This is the first study to systematically analyze the precipitating triggers to neurological symptoms done on the largest cohort of MMA in India.

Methods

A single-centered, cross-sectional observational study, recruiting 160 patients with consecutive angiographically proven MMA over a period of 5 years (2016–2021), was undertaken to evaluate the profile of immediate precipitating factors in temporal association to the neurological symptoms, along with their clinical and radiological characteristics. SPSS 25 was used for statistical analysis.

Results

Among the 160 patients (Adult-85, children-75), precipitating factors were seen in 41.3%, significantly higher in children (52%) than adults (31.8%) (p value: 0.011). The commonest triggers included fever (18.8%), emotional stress (8.1%), heavy exercise and diarrhea (6.3% each). Cold bath triggered MMA symptoms in 1.3%. Fever (p value: 0.008) and persistent crying (p value: 0.010) triggered neurological symptoms more commonly in children than in adults. Amongst MMA patients with precipitating factors, the commonest MMA presentation included cerebral infarction type (37.9%) and TIA (31.8%). The majority of precipitating factors that preceded an ischemic event were BP-lowing ones (54.7%).

Conclusion

Neurological symptoms of MMA are commonly associated with several precipitating factors, including the lesser known triggers like cold bath. The frequency and profile precipitating factors varies with the age of presentation and type of MMA. It can serve as an early clue to the diagnosis of MMA and its careful avoidance can be largely beneficial in limiting the distressing transient neurological symptoms.

Keywords: Moyamoya angiopathy, Precipitating factor, Moyamoya disease, Spicy food, Fever

Introduction

Moyamoya angiopathy (MMA) is a chronic, progressive intracranial vasculopathy characterized by steno-occlusive lesions of intracranial anterior circulation large vessels with compensatory collateral formation [14]. Chronic cerebral hypoperfusion secondary to both occlusion and steal phenomenon leads to ischemic presentation in MMA, and is seen in both adults and children [57]. The neurological manifestations in MMA has been closely described in association with several precipitating factors like fever, diarrhea, heavy exercise, crying and hyperventilation, spicy food intake and hot bath [8, 9]. Recently, the precipitation of MMA following Covid-19 vaccination has also been described [10]. However, literature pertaining to the exact frequency of precipitating factors and its clinical implication is sparse. Ours is the first study to systematically analyze the specific triggers to neurological symptoms in MMA, done in the largest cohort of MMA patients in India. We also herein report cold bath as a trigger to neurological symptoms in MMA, which to the best of our knowledge has not been described previously.

Methodology

A descriptive, observational, cross-sectional study was undertaken from a single, tertiary-care-centre (Bangur Institute of Neurosciences, Kolkata) over a period of 5-years (2016–2021) recruiting 160 consecutive angiographically proven MMA patients with bilateral disease. Each patient was scrutinized for clinical and radiological characteristics. Perfusion study in the form of Single-photon emission computerized tomography (SPECT) was done for cerebral blood flow and cerebrovascular reserve index. All of them were systematically questioned regarding any precipitating factor which occurs in temporal association to the neurological symptoms in the patient (Table 1). The documentation was based on the history given by patient’s kin (for children with MMA) or self-recollection for adult patients. The precipitating factor was considered if it occurred within 15 min prior to onset of neurological symptoms. Exception was made for fever and diarrhea as precipitating factors, for which latency was considered as within hours. Fever was defined as oral temperature greater than 37.7 °C (> 99.9 °F). Diarrhea was defined as 3 or more loose stools per day. For rest of the precipitating factors, standardization was not possible due to cultural and social heterogeneity. Their mere presence or absence from a qualitative history was considered for the study. Thorough investigations were done to identify any secondary cause of MMA. All additional work-up was done depending on the clinical need case-to-case basis. All patient with history of precipitating factors were followed up for 6 months and reassessed in terms of frequency and duration of episodes of perfusion-dependent transient neurological symptoms (TIA, vascular type headache, transient EPS like chorea) in comparison to their status at diagnosis and any new onset fixed neurological symptom (fixed motor weakness, visual symptoms excluding amaurosis fugax, cognitive decline, fixed extra-pyramidal symptoms). SPSS 25 was used for statistical analysis. Data were summarized by routine descriptive statistics, namely mean and standard deviation for numerical variables that are normally distributed, median and inter-quartile range (IQR) for skewed numerical variables and counts and percentages for categorical variables. Numerical variables were compared between two groups by Student’s independent samples t test, if normally distributed, or by Mann–Whitney U test, if otherwise. For multiple group comparison of skewed variables, Kruskal–Wallis ANOVA was used followed by Dunn’s test for post hoc comparisons between two individual groups. Fischer’s exact test or Pearson’s Chi-square test were employed for intergroup comparisons of categorical variables. Analyses were two-tailed and statistical significance level was set at p < 0.05 for all comparisons. The study was undertaken following the consent of institutional ethical committee.

Table 1.

Questionnaire regarding the precipitating factor occurring in temporal association to the neurological symptoms

Did you have neurological symptoms (TIA, vascular type headache, transient or fixed EPS like chorea, fixed motor weakness or cognitive and behavioral symptoms) following occurrence of-
1. Fever Yes/no
2. Exercise Yes/no
3. Spicy food Yes/no
4. Hot bath Yes/no
5. Cold bath Yes/no
6. Crying Yes/no
7. Emotional stress Yes/no
8. Diarrhea Yes/no

Results

Among the 160 MMA patients, all the patients had bilateral disease, 85 had adult-onset MMA and 75 had childhood-onset MMA. The presence of immediate precipitating factor was seen in 66 (41.3%) out of the 160 MMA patients, significantly higher among children (52%) than adults (31.8%) (p value 0.011). The commonest triggers included fever (18.8%), emotional stress (8.1%), heavy exercise and diarrhea (6.3% each). The precipitation of MMA symptoms in temporal relation to fever and persistent crying was significantly higher in children than adults (p-value 0.008 and 0.010 respectively). Amongst the MMA cohort with presence of precipitating factor, mean age of onset of first neurological symptoms was 15.9 ± 15.9 years (median 9.0 years, range 3.5–24.3 years), followed by mean interval of 32.2 ± 58.6 months (median 12.0 months, range 0.0–36.0 months) and ultimately final diagnosis occurred at the mean age of 18.6 ± 16.3 years (median 12.0 years, range 4.8–31.5 years). The presence of one and two precipitating factors were seen in 72.7% and 19.7% patients with triggers respectively, while three or more triggers were seen in 7.6%, no significant differences in adult or child was noted. There was no instance of simultaneous occurrence of two or more trigger in any of our patient. The commonest MMA types associated with precipitating factors were cerebral infarction and TIA comprising of 37.9% and 31.8% of MMA cohort with triggers respectively. Baseline bihemispheric cerebral hypoperfusion was noted in 77.3%, while absence of hypoperfusion was noted in 4.5% of MMA patients with trigger. A presence of precipitating factor lowering blood pressure (BP) (fever, hot bath) was noted in 54.7% of ischemic events (p value 0.579), compared to presence of precipitating factor known to elevate blood BP (exercise, emotional stress) which was seen in of 28.3% of ischemic events (p value 0.080), amongst the MMA cohort with triggers. Hemorrhagic event was seen in only 2 out of the 66 patients with triggers. Results of base-line characteristics are summarized in Tables 2, 3, 4.

Table 2.

Frequency of precipitating factors in the whole cohort

Overall (n = 160) Adult (n = 85) Child (n = 75) p value
Precipitating factor
 Present 66 (41.3%) 27 (31.8%) 39 (52.0%) 0.011
 Absent 94 (58.7%) 58 (68.2%) 36 (48.0%)

Table 3.

List and frequency of precipitating factors among children and adult:

Overall (n = 160) Children (n = 75) Adults (n = 85) p value
Precipitating factor history
 1. Fever 30 (18.75) 21 (28.00) 9 (10.59) 0.008
 2. Heavy exercise 10 (6.25) 5 (6.67) 5 (5.88) 1.000
 3. Spicy food 12 (7.50) 9 (12.00) 3 (3.53) 0.068
 4. Hot bath 8 (5.00) 5 (6.67) 3 (3.53) 0.476
 5. Cold bath 2 (1.25) 2 (2.67) 0.218
 6. Crying 6 (3.75) 6 (8.00) 0.010
 7. Emotional stress 13 (8.13) 3 (4.00) 10 (11.76) 0.087
 8. Diarrhea 10 (6.25) 5 (6.67) 5 (5.88) 1.000

Table 4.

Baseline clinical characteristics, number of precipitating factor in each patient, distribution of precipitating factor in relation to the type of MMA presentation and perfusion status at base-line in the cohort of MMA patients with history of precipitating factor:

Overall (n = 66) Adult (n = 27) Child (n = 39) p value
1. Sex ratio (male:female) 1:2 1:2.9 1:1.6 0.288
2. Area of residence
 Rural 69.7% 70.4% 69.2%
 Urban 30.3% 29.6% 30.8%
3. Mean age at onset of first neurological symptoms (years)

15.9 ± 15.9

Median with range: 9.0 (3.5–24.3)

32.0 ± 12.8

Median with range: 32.0 (19.0–42.0)

4.8 ± 3.0

Median with range: 4.0 (2.5–6.5)

4. Mean age at diagnosis (years)

18.6 ± 16.3

Median with range: 12.0 (4.6–31.5)

34.0 ± 13.2

Median with range: 37.0 (21.0–45.0)

7.9 ± 7.1

Median with range: 6.0 (3.5–11.0)

5. Latency: First appearance of neurological symptoms to confirmed diagnosis (months)

32.2 ± 58.6

Median with range: 12.0 (0–36.0)

25.1 ± 48.8

Median with range: 12.0 (0–24.0)

37.2 ± 64.7

Median with range: 12.0 (0–36.0)

6. Number of precipitating factors
 (a) One 48 (72.7%) 22(81.5%) 26(66.7%) 0.334
 (b) Two 13 (19.7%) 3(11.1%) 10(25.6%)
 (c) Three or more 5 (7.6%) 2(7.4%) 3(7.7%)
7. Presence of precipitating factor according disease presentation type
 (a) TIA 21(31.8%) 8(29.6%) 13(33.3%) 0.751
 (b) Cerebral infarction 32(48.5%) 9(33.3%) 23(59.0%) 0.040
 (c) Hemorrhage 2(3.0%) 2(7.4%) 0 0.084
 (d) Headache 11(16.7%) 8(29.6%) 3(7.7%) 0.019
8. Cerebral Perfusion status at baseline
 (a) Bihemispherical hypoperfusion 51 (77.3%) 19(70.4%) 32(82.1%) 0.359
 (b) Unihemispherical hypoperfusion 12 (18.2%) 7(25.9%) 5(12.8%)
 (c) No hypoperfusion 3 (4.5%) 1(3.7%) 2(5.1%)

Reassessment at follow-up after 6 month period revealed, among the 66 MMA patients with history of precipitating factor, none of them had any new onset of fixed neurological symptom, while 28 (42.4%) of them had decrease (either in frequency or severity or both)in their perfusion-dependent transient neurological symptom (TIA or headache).

Case presentation: A 5-year-old boy from rural Bengal presented to us with five episodes of transient left hemiparesis with slurring of speech and one episode of right fixed hemiparesis in the last 10 months. On detailed history-taking, the mother revealed that all the episodes have occurred during or immediately following bath in cold water. Magnetic resonance imaging (MRI) brain revealed T2/FLAIR multiple foci of white matter signal changes in the right subcortical, periventricular region with cystic changes. Magnetic resonance angiography (MRA) showed occlusive changes involving bilateral distal ICA, proximal MCA and right ACA, with collateral formation, suggestive of MMA. Brain SPECT revealed reduced perfusion with significantly impaired cerebral vascular reserve in bilateral ACA and MCA territories. The patient’s kin was counseled in details regarding the avoidance of cold water bath. The patient had no further TIA or new-onset fixed neurological deficit at 6 month follow-up period.

Discussion

MMA can be considered as a model of hemodynamic insufficiency, wherein depending on the adequacy of collateral status, reduced cerebral perfusion pressure and ultimately decreased blood flow may occur distally. Despite autoregulatory vasodilation and increased oxygen extraction fraction acting as compensatory mechanisms, impaired hemodynamics lends a major risk of future cerebrovascular events in these patients [11]. Kraemer et al. observed evidence of syncope in 6.5% of its MMA patients hinting towards a heightened intolerance to orthostatic maneuvers in MMA [6]. MMA often manifests itself, in the face of transient changes in cerebral hypoperfusion caused by various triggering factors, with wide array of paroxysmal and fixed neurological symptoms, depending on the severity and duration of changes in the already compromised cerebral perfusion [7, 1214]. A history of immediate precipitating factor was observed in 41.3% of MMA in our cohort, more frequently in children than adults (p-value 0.011). Thus, it is a frequent finding in MMA. But it is commonly over-looked, possibly due lack of awareness on the part of treating physician of its high incidence and its clinical implication in MMA [5]. Also, younger patients fail to appreciate these triggers themselves, only to be picked up by their vigilant guardians later in the course of the disease and it is also not infrequent for the patients to think that these triggers are unrelated.

Dynamic cerebral autoregulation (CA) normally maintain cerebral blood flow (CBF) homeostasis in normal population. However, it has been seen that dynamic CA is limited in MMA and dynamic, short (± 10–20% of mean arterial pressure) blood pressure (BP) changes can markedly affect CBF (± 10–15%), making them susceptible to hypoperfusion or hyperperfusion related cerebral insults. Thus, maintenance of a strict BP becomes imperative in this population to avoid neurological complications [15]. It may be interesting to note the triggers known to elevate BP like emotional stress and exercise preceded the hemorrhagic events among the two cases in our cohort. Similarly, BP lowering precipitating factors was commoner amongst patients with ischemic events in temporal association than BP elevating factors in our cohort, although statistical significance could not be reached. The development of the pathological collateral systems provides an alternate route for cerebral perfusion in MMA. But it is often insufficient to compensate reduced cerebral perfusion. This is more conspicuous in children than adult MMA, thus making them further vulnerable to changes in BP and precipitating factors known to alter the cerebral perfusion [1517].

Fever and increased body temperature can potentiate symptoms of MMA related to hemodynamic stress. Our findings resonate with the observation by Das et al., wherein Covid-19 infections precipitated MMA symptoms [14, 18, 19]. It has been seen that there is a marked drop of central blood-pressure post bath in hot water that can persist for 45–60 min. This can further lead to decompensation of already compromised cerebral circulation and seems to be the major drive in precipitation of neurological symptoms following hot bath [20, 21]. Cold water bath related potentiation of MMA symptoms may be hypothesized to the fact that a abrupt fall in skin temperature can lead to powerful cardio-respiratory changes called as the “cold shock” response, this leads to hyperventilation and subsequent decrease in cerebral blood flow (CBF). Besides, corroborative evidence suggests that repeated cold exposure can modulate endothelial nitric oxide (NO) synthase and bioavailability of NO and impair endothelial vasodilatory function [2224]. Chen et al. described a case of MMA precipitated following whole body cryotherapy and linked the events mechanistically as cryotherapy induced cerebral autonomic dysregulation and vasoconstriction, potentially through transient hyperventilation [25].

Crying as a precipitating factor was significantly commoner in children with MMA, conforming to previous reports. It may be presumed due to the essential differences in susceptibility to ischemia of brain of children and adults. Thus, even a moderate decrease in cerebral perfusion can potentiate ischemic symptoms in children, who have higher cerebral oxygen consumption in comparison to adults. Besides, a child is more prone to crying in response to uncomfortable situation due to its intellectual and emotional immaturity. Other less plausible explanations could be more severely compromised cerebral circulation and possibility of better vasoconstrictive response to hyperventilation in children compared to adults [26].

Hyperventilation-induced intracranial vasoconstriction subsequent decrease in cerebral perfusion is a result of hypocapnia. Crying and intake of spicy food causes precipitation of ischemic symptoms chiefly by the mechanism of hyperventilation. Besides, spicy food can lead to increased blood flow through external carotid artery (ECA) to oral glands and mucosa causing a “steal phenomenon” to the anterior cerebral circulation, previously being compensated by collaterals from ECA. Further, spicy food intake causes increased body temperature [9, 2629]. Previous studies have shown exercise induced hyperthermia can lead to decrease in middle cerebral artery (MCA) velocity [30]. Its extrapolation may be reasonable in cases of spicy food intake as well. Exercise, on the other hand, also causes increased hemodynamic demand [9, 31, 32]. Diarrhea and dehydration can lead to decrease in systemic pressure and subsequently diminution of cerebral perfusion [33]. An already compromised cerebral circulation in MMA, is thus often decompensated by this mechanisms leading to manifestation of ischemic symptoms [5, 7, 8].

Acute emotional stress is proposed to enhance the risk of ischemic stroke by excessive sympathomimetic activity and complex interactions of altered coagulation and inflammatory states [3437]. It has been speculated that stress can cause endothelial dysfunction with decreased NO production leading to loss of anti-coagulant and pro-fibrinolytic properties [3436]. This becomes particularly important in individuals with pre-existing vessel lumen compromise. Besides, it can cause alteration of immune system by increasing IL-8, pro-inflammatory TNF- α and unaltered induction of anti-inflammatory cytokine IL-10, which is already known to be implicated in worsening of MMA [34, 3842]. Also, several studies have shown that sympathetic activity can decrease CBF or attenuate CBF increases, but under normal physiological condition neurogenic control has lesser influence over cerebral autoregulation in comparison to vasomotor, metabolic and chemical mechanism. However, in chronic ischemic states, these dominant mechanisms are often overwhelmed and a dysautoregulation secondary to accentuation of neurogenic, sympathetic control of CBF occurs [43]. A similar pathophysiology might be underpinning the precipitation of transient symptoms in MMA secondary to emotional stress leading to sympathetic stimulation.

Certain symptoms in MMA like limb-shaking TIA (LS-TIA) and focal motor seizures are difficult to tell apart. A reliable clinical clue is the history of temporal association of symptom onset to triggers causing cerebral hypoperfusion which usually points towards the diagnosis of LS-TIA [8, 4446].

It was noticed that 4.5% of the patient did not document any evidence of cerebral hypoperfusion on baseline imaging. They were only decompensated on exposure to precipitating factors leading to manifestation of transient neurological symptoms. Though a very minor fraction, these patients can greatly benefit from detailed elicitation and attribution of these triggers to an underlying occlusive vasculopathy, which can aid in early diagnosis and better prognostication. It was further observed that careful avoidance of the specific precipitating factors led to decrease of transient neurological symptoms, in either severity or frequency or both, among 42.4% patients with history of precipitating factors and none of them had new onset fixed motor neuro-deficit over a follow-up period of 6 months. This is likely due to reduction of transient worsening of the cerebral perfusion in the absence of triggers. Behavioral therapy promoting avoidance of preventable triggers can be useful. Physical measures aiding in blood pressure regulation, drinking adequate fluids and occasional use of compression hosiery can greatly aid in maintenance of blood volume and subsequently cerebral perfusion. This undermines the importance of meticulous elicitation of history of such triggering factors which can greatly aid in decreasing the distressing neurological symptoms while a definite therapy for MMA is awaited. This is especially important in countries like India, where the health-care system is not robust and MMA patients have to travel great distances to avail centers with facilities for revascularization surgery [5, 7, 8, 45].

This is the first study to explore the effects of triggering factors in MMA patients. The potential limitation includes a single-centered observational study. A perfusion study at follow-up period could have further strengthened the observations. However, the strength lies in the relatively large cohort of MMA patients included in the study.

Conclusion

MMA is frequently associated with triggers that can cause transient cerebral hypoperfusion, more common in children than adult-onset MMA. Certain precipitating factor can affect an age group more commonly, crying more commonly potentiated ischemic symptoms in children. It can be an early clue to diagnosis in MMA, even before the setting of cerebral hypoperfusion. A careful avoidance of these factors can help alleviate distressing transient neurological symptoms, which is especially beneficial in resource-limited setting.

Author contributions

SD: conceptualization-equal, data curation-lead, formal analysis-equal, investigation-equal, methodology-equal, resources-equal, supervision-equal, visualization-equal, writing-original draft-lead, writing-review & editing-equal. BR conceptualization-equal, formal analysis-equal, project administration-equal, supervision-equal, visualization-equal, writing-review & editing-equal. AP conceptualization-equal, formal analysis-equal, supervision-equal, visualization-equal, writing-review & editing-equal. RG writing-review & editing-equal. RD writing-review & editing-equal. SD conceptualization-equal, formal analysis-equal, methodology-equal, project administration-equal, supervision-equal, visualization-equal, writing-review & editing-lead. MK supervision-equal, visualization-equal, writing-review & editing-lead.

Funding

The authors have stated that there was no funding source in connection to this work and article.

Data availability

Data not provided in the article because of space limitations may be shared (anonymized) at the request of any qualified investigator for the purposes of replicating procedures and results.

Declarations

Conflicts of interest

The authors have stated explicitly that there are no conflicts of interest in connection with this article.

Informed consent

Written informed consent was obtained from all individual participants included in the study.

Role of medical writer or editor

No medical writer or editor help was taken during the preparation of this manuscript.

Research involving human participants and/or animals

Approval was obtained from the ethics committee of Institute of Post-graduate Medical Education & Research, Kolkata, India. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. (Ethics committee reference number- ECR/35/Inst/WB/2013/RR-16).

Authorship agreement

I, Dr Markus Kraemer take full responsibility for the data, the analyses and interpretation, and the conduct of the research. I have full access to all the data and have the right to publish any and all data, separate and apart from the guidance of any sponsor.

Contributor Information

Shambaditya Das, Email: drshambadityadas@gmail.com.

Biman Kanti Ray, Email: bimankantiray2019@gmail.com.

Alak Pandit, Email: dralakpandit@gmail.com.

Ritwik Ghosh, Email: ritwikmed2014@gmail.com.

Rolf Diehl, Email: rolf.diehl@krupp-krankenhaus.de.

Souvik Dubey, Email: drsouvik79@gmail.com.

Markus Kraemer, Email: markus.kraemer@krupp-krankenhaus.de.

References

  • 1.Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med [Internet]. 360(12):1226–37. http://www.nejm.org/doi/abs/10.1056/NEJMra0804622. Cited 24 Nov 2018 [DOI] [PubMed]
  • 2.Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H et al. (2022) Moyamoya disease: diagnosis and interventions. Lancet Neurol [Internet]. 21(8):747–58. Available from: http://www.thelancet.com/article/S147444222200165X/fulltext. Cited 4 Oct 2022 [DOI] [PubMed]
  • 3.Pilgram-Pastor S, Chapot R, Kraemer M (2022) The angiographic presentation of European Moyamoya angiopathy. J Neurol 269(2):997–1006. https://link.springer.com/article/10.1007/s00415-021-10684-6. Cited 23 Feb 2022 [DOI] [PMC free article] [PubMed]
  • 4.Das S, Dubey S, Acharya M, Chatterjee S, Lahiri D, Das G et al (2019) Thalassemia and Moyamoya syndrome: unfurling an intriguing association. J Neurol [Internet]. 266(11):2838–47. https://pubmed.ncbi.nlm.nih.gov/31422456/. Cited 30 Aug 2020 [DOI] [PubMed]
  • 5.Das DS, Dubey DS, Acharya DM, Ghosh DR, Chatterjee DS, Hazra PA, et al. The disease presentation of Moyamoya Angiopathy in Eastern India. J Stroke Cerebrovasc Dis. 2020;29(8):104957. doi: 10.1016/j.jstrokecerebrovasdis.2020.104957. [DOI] [PubMed] [Google Scholar]
  • 6.Kraemer M, Schwitalla JC, Diesner F, Aktas O, Hartung HP, Berlit P (2019 ) Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients. J Neurol 266(6):1421–8. Available from: https://link.springer.com/article/10.1007/s00415-019-09277-1. Cited 23 Feb 2022 [DOI] [PubMed]
  • 7.Das S, Dubey S, Das S, Hazra A, Pandit A, Ghosh R et al (2022) Epidemiology of Moyamoya Angiopathy in Eastern India. Front Neurol [Internet]. 282. Available from: https://www.frontiersin.org/articles/10.3389/fneur.2022.837704/full. Cited 9 Mar 2022 [DOI] [PMC free article] [PubMed]
  • 8.Das S, Ghosh R, Dubey S, Pandit A, Ray BK, Kraemer M (2021) Limb-shaking TIA in Moyamoya angiopathy. Clin Neurol Neurosurg 207:106783. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0303846721003127. Cited 5 Jul 2021 [DOI] [PubMed]
  • 9.Dubey S, Ghosh R, Chatterjee S, Dubey MJ, Ray BK, Das S, et al. Spicy foods triggering clinical symptoms in Moyamoya angiopathy. J Neurosurg Sci. 2020;65:85–88. doi: 10.23736/S0390-5616.20.05030-4. [DOI] [PubMed] [Google Scholar]
  • 10.Das S, Kanti Ray B, Pandit A, Dutta A, Bhat S, Bhattacharyya D et al (2022) COVID-19 vaccine (Covishield) heralding Moyamoya angiopathy. Neuroimmunol Reports [Internet]. 2:100100. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2667257X2200047X. Cited 16 May 2022
  • 11.Derdeyn CP (2018) Hemodynamics and oxygen extraction in chronic large artery steno-occlusive disease: clinical applications for predicting stroke risk. J Cereb Blood Flow Metab [Internet]. 38(9):1584–97. Available from: https://pubmed.ncbi.nlm.nih.gov/28925313/. Cited 1 Mar 2022 [DOI] [PMC free article] [PubMed]
  • 12.Vuignier S, Ito M, Kurisu K, Kazumata K, Nakayama N, Shichinohe H, et al (2013) Ivy sign, misery perfusion, and asymptomatic moyamoya disease: FLAIR imaging and 15O-gas positron emission tomography. Acta Neurochir (Wien) [Internet]. 155(11):2097–104. Available from: https://link.springer.com/article/10.1007/s00701-013-1860-4. Cited 5 Jul 2021 [DOI] [PubMed]
  • 13.Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008;39(12):3193–3200. doi: 10.1161/STROKEAHA.107.513408. [DOI] [PubMed] [Google Scholar]
  • 14.Das S, Ray BK, Ghosh R, Sengupta S, Pandit A, Dubey S (2021) Impact of COVID-19 pandemic in natural course of Moyamoya Angiopathy: an experience from tertiary-care-center in India. Egypt J Neurol Psychiatry Neurosurg 571 [Internet]. 57(1):1–6. Available from: https://ejnpn.springeropen.com/articles/10.1186/s41983-021-00412-2. Cited 16 Dec 2021 [DOI] [PMC free article] [PubMed]
  • 15.Liming Z, Weiliang S, Jia J, Hao L, Yang L, Ludtka C et al (2021) Impact of blood pressure changes in cerebral blood perfusion of patients with ischemic Moyamoya disease evaluated by SPECT. J Cereb Blood Flow Metab [Internet]. 41(6):1472–80. Available from: https://pubmed.ncbi.nlm.nih.gov/33153375/. Cited 12 Mar 2022 [DOI] [PMC free article] [PubMed]
  • 16.Pilgram-Pastor S, Chapot R, Kraemer M (2022) The angiographic presentation of European Moyamoya angiopathy. J Neurol [Internet]. 269(2):997–1006. Available from: https://pubmed.ncbi.nlm.nih.gov/34240321/. Cited 12 Mar 2022 [DOI] [PMC free article] [PubMed]
  • 17.Kim JS (2016) Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke [Internet]. 18(1):2–11. Available from: https://pubmed.ncbi.nlm.nih.gov/26846755/. Cited 16 Dec 2021 [DOI] [PMC free article] [PubMed]
  • 18.Ghosh R, Dubey S, Kanti Ray B, Chatterjee S, Benito-León J (2020) COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy [Internet]. vol. 47, Canadian Journal of Neurological Sciences. Cambridge University Press; pp 849–51. Available from: /pmc/articles/PMC7327161/. Cited 18 Mar 2021 [DOI] [PMC free article] [PubMed]
  • 19.Das S, Dubey S, Pandit A, Ray BK (2021) Moyamoya angiopathy unmasking systemic lupus erythematosus. BMJ Case Rep [Internet]. 14(1):e239307. Available from: https://casereports.bmj.com/content/14/1/e239307. Cited 27 Feb 2021 [DOI] [PMC free article] [PubMed]
  • 20.Ishikawa J, Yoshino Y, Watanabe S, Harada K (2016) Reduction in central blood pressure after bathing in hot water. Blood Press Monit [Internet] 21(2):80–6. Available from: https://pubmed.ncbi.nlm.nih.gov/26657048/. Cited 11 Mar 2022 [DOI] [PubMed]
  • 21.Kim J Bin, Yu S (2013) Transient ischemic attack after hot bath in a patient with Moyamoya disease. Neurol Sci [Internet]. 34(12):2231–3. Available from: https://koreauniv.pure.elsevier.com/en/publications/transient-ischemic-attack-after-hot-bath-in-a-patient-with-moyamo. Cited 23 Feb 2022 [DOI] [PubMed]
  • 22.Barwood M, Burrows H, Cessford J, Fraser L, Goodall S, Griffiths S (2015) Brain blood flow and hyperventilation on cold water immersion: can treading water help control these symptoms of cold shock? Extrem Physiol Med 41 4(1):1–2. Available from: https://extremephysiolmed.biomedcentral.com/articles/10.1186/2046-7648-4-S1-A40. Cited 23 Feb 2022
  • 23.Kjeld T, Pott FC, Secher NH (2009) Facial immersion in cold water enhances cerebral blood velocity during breath-hold exercise in humans. J Appl Physiol 106(4):1243–8. Available from: https://pubmed.ncbi.nlm.nih.gov/19179653/. Cited 23 Feb 2022 [DOI] [PubMed]
  • 24.Benedict PS, Pandian JD (2014) Stroke after cold bath. CHRISMED J Heal Res [Internet]. 1(4):283. Available from: https://www.cjhr.org/article.asp?issn=2348-3334;year=2014;volume=1;issue=4;spage=283;epage=285;aulast=Benedict. Cited 23 Feb 2022
  • 25.Chen PM, Chen MM, Chiang CC, Olson S, Bolar DS, Agrawal K (2020) Moyamoya presenting after whole body cryotherapy [Internet]. vol. 29, Acta Neurologica Taiwanica. p. 64–6. Available from: https://pubmed.ncbi.nlm.nih.gov/32436205/. Cited 11 Mar 2022 [PubMed]
  • 26.Tagawa T, Naritomi H, Mimaki T, Yabuuchi H, Sawada T (1987) Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease. Stroke [Internet]. 18(5):906–10. Available from: https://www.ahajournals.org/doi/abs/10.1161/01.str.18.5.906. Cited 23 Feb 2022 [DOI] [PubMed]
  • 27.Storozhuk MV, Moroz OF, Zholos AV. Multifunctional TRPV1 ion channels in physiology and pathology with focus on the brain, vasculature, and some visceral systems. Biomed Res Int. 2019 doi: 10.1155/2019/5806321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ma L, Lee BH, Mao R, Cai A, Jia Y, Clifton H et al (2014) Nicotinic acid activates the capsaicin receptor TRPV1—a potential mechanism for cutaneous flushing. Arterioscler Thromb Vasc Biol [Internet]. 34(6):1272. Available from: /pmc/articles/PMC4063526/. Cited 18 Apr 2022 [DOI] [PMC free article] [PubMed]
  • 29.Boudreau SA, Wang K, Svensson P, Sessle BJ, Arendt-Nielsen L (2009) Vascular and psychophysical effects of topical capsaicin application to orofacial tissues. J Orofac Pain [Internet]. 23(3):253. Available from: /pmc/articles/PMC3069052/. Cited 18 Apr 2022 [PMC free article] [PubMed]
  • 30.Nybo L, Nielsen B (2001) Middle cerebral artery blood velocity is reduced with hyperthermia during prolonged exercise in humans. J Physiol [Internet] 534(Pt 1):279–86. Available from: https://pubmed.ncbi.nlm.nih.gov/11433008/. Cited 16 May 2022 [DOI] [PMC free article] [PubMed]
  • 31.Mustafa S, Thulesius O, Ismael HN (2004) Hyperthermia-induced vasoconstriction of the carotid artery, a possible causative factor of heatstroke. J Appl Physiol [Internet]. 96(5):1875–8. Available from: https://pubmed.ncbi.nlm.nih.gov/15075312/. Cited 23 Feb 2022 [DOI] [PubMed]
  • 32.Shoukat S, Itrat A, Taqui AM, Zaidi M, Kamal AK (2009) Moyamoya disease: a clinical spectrum, literature review and case series from a tertiary care hospital in Pakistan. BMC Neurol [Internet]. 9. Available from: https://pubmed.ncbi.nlm.nih.gov/19368734/. Cited 23 Feb 2022 [DOI] [PMC free article] [PubMed]
  • 33.Trangmar SJ, Chiesa ST, Llodio I, Garcia B, Kalsi KK, Secher NH et al (2015) Dehydration accelerates reductions in cerebral blood flow during prolonged exercise in the heat without compromising brain metabolism. Am J Physiol - Hear Circ Physiol [Internet]. 309(9):H1598. Available from: /pmc/articles/PMC4670459/. Cited 16 May 2022 [DOI] [PMC free article] [PubMed]
  • 34.Kotlęga D, Gołąb-Janowska M, Masztalewicz M, Ciećwież S, Nowacki P (2016) The emotional stress and risk of ischemic stroke. Neurol Neurochir Pol [Internet]. 50(4):265–70. Available from: https://pubmed.ncbi.nlm.nih.gov/27375141/. Cited 23 Feb 2022 [DOI] [PubMed]
  • 35.R Kanel PMCFJD (2001) Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis [Internet]. Psychosom Med. 63:531–44. Available from: https://journals.lww.com/psychosomaticmedicine/Abstract/2001/07000/Effects_of_Psychological_Stress_and_Psychiatric.3.aspx. Cited 16 May 2022 [DOI] [PubMed]
  • 36.Von Känel R (2015) Acute mental stress and hemostasis: when physiology becomes vascular harm. Thromb Res [Internet]. 135(S1):S52–5. Available from: http://www.thrombosisresearch.com/article/S0049384815504441/fulltext. Cited 16 May 2022 [DOI] [PubMed]
  • 37.Austin AW, Wissmann T, Von Kanel R (2013) Stress and hemostasis: an update. Semin Thromb Hemost [Internet]. 39(8):902–12. Available from: http://www.thieme-connect.de/products/ejournals/html/10.1055/s-0033-1357487. Cited 16 May 2022 [DOI] [PubMed]
  • 38.Limb-shaking TIA related to moyamoya disease: diagnosis with magnetic resonance imaging and magnetic resonance angiography - PubMed [Internet]. Available from: https://pubmed.ncbi.nlm.nih.gov/21210328/. Cited 4 Jan 2021 [PubMed]
  • 39.Yashar VB, Barenholz Y, Hy‐Am E, Rachmilewitz EA, Eldor A (1993) Phosphatidylserine in the outer leaflet of red blood cells from β‐thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol [Internet]. 44(1):63–5. Available from: https://pubmed.ncbi.nlm.nih.gov/8342566/. Cited 8 Mar 2021 [DOI] [PubMed]
  • 40.Bersano A, Guey S, Bedini G, Nava S, Hervé D, Vajkoczy P et al. (2016) Research progresses in understanding the pathophysiology of moyamoya disease. Cerebrovasc Dis [Internet]. 41(3–4):105–18. Available from: https://www.karger.com/Article/FullText/442298. Cited 8 Mar 2021 [DOI] [PubMed]
  • 41.Lyoo CH, Oh SH, Joo JY, Chung TS, Lee MS (2000) Hemidystonia and hemichoreoathetosis as an initial manifestation of moyamoya disease. Arch Neurol [Internet]. 57(10):1510–2. Available from: https://jamanetwork.com/journals/jamaneurology/fullarticle/777669. Cited 23 Feb 2022 [DOI] [PubMed]
  • 42.van Westerloo DJ, Choi G, Löwenberg EC, Truijen J, de Vos AF, Endert E et al (2011) Acute stress elicited by bungee jumping suppresses human innate immunity. Mol Med 17(3):180–8. Available from: https://molmed.biomedcentral.com/articles/10.2119/molmed.2010.00204. Cited 16 May 2022 [DOI] [PMC free article] [PubMed]
  • 43.Ter Laan M, Van Dijk JMC, Elting JWJ, Staal MJ, Absalom AR (2013) Sympathetic regulation of cerebral blood flow in humans: a review. Br J Anaesth [Internet]. 111(3):361–7. Available from: https://pubmed.ncbi.nlm.nih.gov/23616589/. Cited 12 Mar 2022 [DOI] [PubMed]
  • 44.Kraemer M, Trakolis L, Platzen J, Schwitalla JC, Bersano A, Albrecht P, et al. Movement symptoms in European Moyamoya angiopathy–first systematic questionnaire study. Clin Neurol Neurosurg. 2017;1(152):52–56. doi: 10.1016/j.clineuro.2016.11.017. [DOI] [PubMed] [Google Scholar]
  • 45.Das S, Ray BK, Ghosh R, Dubey S (2022) “Asymptomatic” Moyamoya angiopathy: is it truly asymptomatic? J Stroke Cerebrovasc Dis [Internet] 31(6):106432. Available from: http://www.strokejournal.org/article/S105230572200129X/fulltext. Cited 9 Apr 2022 [DOI] [PubMed]
  • 46.Das S, Ray BK, Dubey S (2021) Temporal lobe epilepsy with nocturnal wandering leading to discovery of Moyamoya Angiopathy. Acta Neurol Belgica [Internet]. 1–3. Available from: https://link.springer.com/article/10.1007/s13760-021-01830-y. Cited 2 Dec 2021 [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data not provided in the article because of space limitations may be shared (anonymized) at the request of any qualified investigator for the purposes of replicating procedures and results.


Articles from Journal of Neurology are provided here courtesy of Nature Publishing Group

RESOURCES